MARINOSOLV Technology

Competitor Budesonide nasal spray (left) and MARINOSOLV® enabled Budesonide nasal spray (right). Source: Marinomed

Marinomed offers the MARINOSOLV® technology to interested parties. Please contact our BD&L department for further information.

TECHNOLOGY FOR HEALTH

THE PATENT PROTECTED MARINOSOLV® PLATFORM

The patent protected MARINOSOLV® platform enables novel stable aqueous formulations of hardly soluble compounds such as corticosteroids, allowing a faster onset of action and a better bioavailability.

The MARINOSOLV® technology is not limited to a specific compound and has the potential to facilitate delivery of any compound with solubility issues.

MARINOSOLV® is superior when sensitive tissues such as those of the eye, nose, lung or others are targeted. Marinomed has extensive experience in developing and commercialization of products for respiratory and ocular disorders